¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"BODI Line ALMOND SKIN CARE Top"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • scalded skin syndrome
    È­»óÇǺÎÁõÈıº
  • split-thickness skin graft
    ºÎºÐÃþÇǺÎÀ̽Ä
  • staphylococcal scalded skin syndrome
    Æ÷µµ¾Ë±Õ¼º¿­»óÇǺÎÁõÈıº, Æ÷µµ±¸±Õ¼º¿­»óÇǺÎÁõÈıº
  • sailor¡¯s skin
    ¹î»ç¶÷ÇǺÎ
  • skin
    ÇǺÎ
  • skin appendage
    ÇǺκμӱâ(°ü)
  • skin dose
    ÇǺμ±·®
  • skin flap
    ÇÇºÎÆÇ, ÇÇÆÇ
  • skin flap blepharoplasty
    ÇÇºÎÆÇ´«²¨Ç®¼ºÇü(¼ú), ÇÇºÎÆÇ¾È°Ë¼ºÇü(¼ú)
  • skin flare
    ÇǺιßÀû
  • skin friction
    ÇǺθ¶Âû
  • skin graft
    1. ÇǺÎÀÌ½Ä 2. ÇǺÎÀÌ½ÄÆí
  • skin graft inlay
    ¼Ó³Ö±âÇǺÎÀ̽Ä, °¨ÀÔÇǺÎÀ̽Ä
  • skin lesion
    ÇǺκ´ÅÍ, ÇǺÎȯºÎ
  • skin manifestation
    ÇǺμҰß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • skin flap
    ÇÇºÎÆÇ
  • skin flare
    ÇǺιßÀû
  • skin friction
    ÇǺθ¶Âû
  • skin vascular permeability factor
    ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
  • galvanic skin reflex
    Àü±âÇǺιݻç
  • galvanic skin response
    Àü±âÇǺιÝÀÀ
  • glabrous skin
    Åоø´ÂÇǺÎ
  • glossy skin
    ±¤ÅÃÇǺÎ
  • goose flesh skin
    ¼Ò¸§
  • split-skin graft
    ºÎºÐÃþÇǺÎÀ̽Ä
  • hairy skin receptor
    ÅÐÇǺμö¿ëü
  • infantile stiff skin syndrome
    ¿µ¾ÆÇǺΰæÁ÷ÁõÈıº
  • skin graft inlay
    ¼Ó³Ö±âÇǺÎÀ̽Ä, °¨ÀÔÇǺÎÀ̽Ä
  • leopard skin
    Ç¥¹üÇǺÎ
  • lizard skin
    µµ¸¶¹ìÇǺÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • KCL =keratoconus line
    ¿ø»Ô°¢¸·¼±.
  • Kerley s A line
    Äø® A¼±.
  • Kerley s B line
    Äø® B¼±.
  • Kerley s C line
    Äø® C¼±.
  • Kerleys A line
    Äø® A¼±
  • Kerleys B line
    Äø® B¼±
  • Kerleys C line
    Äø® C¼±
  • Kerleys D line
    Äø® D¼±
  • Langer line
    ¶û°Å¼±
  • Mees line
    ¹ÌÁî¼±
  • Sampaolesis line
    »ïÆú·¹½Ã»ö¼Ò¼±
  • Staehlis line
    ½ºÅÚ¸®¼±
  • Stocker line
    ½ºÅåÄ¿¼±
  • Vogts line
    º¸Å©Æ®¼±
  • Voigt line
    Æ÷ÀÌÆ®¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • antibody, skin sensitizing
    ÇǺΰ¨ÀÛÇ×ü
  • appendages of skin
    ÇǺκμӹ°
  • artificial skin
    ÀΰøÇǺÎ(¡­ù«Ý±).
  • artificial skin
    ÀΰøÇǺÎ(¡­ù«Ý±)
  • artificial skin graft
    Àΰø ÇǺÎÀ̽Ä
  • audiometry, galvanic skin response =GSR-a.
    ÇǺÎÀü±â¹ÝÀÀ û·Â°Ë»ç
  • bronze skin
    ûµ¿»öÇǺÎ(¡­ù«Ý±)
  • chapping of skin
    ÇǺαտ­
  • clammy skin
    ³Ã½ÀÇǺÎ(ÕÒã¥ù«Ý±)
  • colar, skin
    ÇǺλöÁ¶
  • congenital localized absence of skin
    ¼±Ãµ¼º(à»ô¸àõ) ±¹¼Ò ÇǺΠ°á¼Õ
  • congestive skin
    ÇǺοïÇ÷(¡­ê¦úì)
  • cutaneous allergy = skin a.
    ÇǺξ˷¹¸£±â
  • cutaneous allergy =skin a.
    ÇǺξ˷¹¸£±â.
  • distant skin pedicle
    ¿ø°ÝÇÇÆÇ(¡­ù«÷û)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ICU infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit
NICU neonatal intensive care unit; neurological intensive care unit; neurosurgical intensive care unit; n...
PCCM pediatric critical care medicine; primary care case management; primary care case manager
PCP parachlorophenate; patient care plan; pentachlorophenol; 1-(1-phenylcyclohexyl)piperidine; periphera...
PCS palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
TCL T cell line
TCLA T cell line adapted
T-tropic T cell line-tropic
C-6 cell line
CTLL cytotoxic T cell line
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mesiobuccal line angle labial groove
    ±Ù½É Çù ±³ÇÕ¸é ÷°¢ ¼ø¸é ±¸
  • midaxillary line
    ¾×¿Í Áß¾Ó¼±
  • mylohyoid line
    ¾Ç¼³°ñ ¼±, ÇÏ¾Ç ¼³°ñ±Ù ¼±, ¾Ç¼³°ñ±Ù ¼±
  • neonatal line
    ù ¼ºÀå¼±
  • parasternal line
    º¹Àå ¿·¼±
  • plumb line
    Ãß¼±
  • prosthesis cement lucent line
    Àΰø¹° ½Ã¸àÆ® ¹æ»ç¼º Åõ°ú¼±
  • pulpo-axial line angle
    Ä¡¼öº® Ãຮ ¼±°¢
  • reinforcement line
    °­È­¼±
  • retentive fulcrum line
    À¯Áö ±¸°£¼±, À¯Áö ÁöÁ¡¼±
  • rough line
    Á¶¼±
  • septal line
    Á߰ݼ±
    Ä«·¹ ¥â ¼±
  • Shenton's line
    ¼Ïư ¼±
    °í°üÀý ºÎÀ§ÀÇ X-¼± Áø´ÜÀ¸·Î, ƯÈ÷ Å»±¸ÀÇ À¯¹« °Ë»ç¿¡ ¾²ÀδÙ.
  • slip line
    ¹Ì²ô·³ ¼±
  • smile line
    ¹Ì¼Ò¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
primary care The medical home for a patient, ideally providing continuity and integration of health care. All family physicians and most paediatricians and internists are in primary care. The aims of primary care are to provide the patient with a broad spectrum of care, both preventive and curative, over a period of time and to coordinate all of the care the patient receives.
(12 Dec 1998)
health care finance administration See: HCFA.
(12 Dec 1998)
Health Care Financing Administration The federal agency that determines reimbursement for federal programs.
(05 Mar 2000)
health care proxy A health care proxy is one form of advance medical directive. Advance medical directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There are two basic forms of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (this entry is based upon material from the national ms society).
(12 Dec 1998)
health care quality, access, and evaluation The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery.
(12 Dec 1998)
health care rationing Planning for the equitable allocation, apportionment, or distribution of available health resources.
(12 Dec 1998)
health care reform Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services.
(12 Dec 1998)
health care sector Economic sector concerned with the provision, distribution, and consumption of health care services and related products.
(12 Dec 1998)
health care surveys Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.
(12 Dec 1998)
primary health care Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (jama 1995;273(3):192)
(12 Dec 1998)
primary medical care Care of a patient by a member of the health care system who has initial contact with the patient.
(05 Mar 2000)
primary nursing care The primary responsibility of one nurse for the planning, evaluation, and care of a patient throughout the course of illness, convalescence, and recovery.
(12 Dec 1998)
progressive patient care Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organised home care.
(12 Dec 1998)
proxy, health care A health care proxy is one form of advance medical directive. Advance medical directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There are two basic forms of advance directives:
1. A living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers.
2. A health care proxy (also called a power of attorney for health-care decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (this entry is based upon material from the national ms society).
(12 Dec 1998)
secondary medical care Medical care by a physician who acts as a consultant at the request of the primary physician.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • main line
    °£¼±
  • two-line
    ¹èÇüÀÇ
  • A line
    ¶óÀÎÀÇ;A¶óÀÎÀÇ(¿©¼ºº¹ÀÌ AÀÚó·³ À§°¡ Á¼°í ¹ØÀÌ ÆÛÁü)
  • DEW line
    µà¶óÀÎ(ºÏ±Ø±Ç ºÏºÎ¿¡ ÀÖ´Â ¹Ì±¹.ij³ª´Ù °øµ¿ÀÇ ¿ø°Å¸®Á¶±â °æº¸¸Á)
  • Distant Early Warning line
    =DEW LINE
  • Gray Line
    ¹Ì±¹ÀÇ ´ë±Ô¸ð °ü±¤¹ö½º ȸ»ç
  • International Date Line
    ±¹Á¦ ³¯Â¥ º¯°æ¼±(IDL)
  • Mason Dixon line
    MarylandÁÖ¿Í PennsylvaniaÁÖÀÇ °æ°è¼±(³ë¿¹ ½Ã´ëÀÇ ³²ºÏ °æ°è¼±,ÇöÀç´Â ¹æ¾ð ±¸ºÐ¼±ÀÇ Çϳª)
  • Siegfried Line
    ÁöÅ©ÇÁ¸®Æ®¼±;Á¦ 2Â÷ ´ëÀü¿¡ ¾Õ¼­ µ¶ÀÏÀÌ ±¸ÃàÇÑ ¼­ºÎÀÏ´ëÀÇ ¿ä»õ¼±
  • assembly line
    ÀϰüÀÛ¾÷Á¶Á÷
  • base line
    ±âÁؼ±;´©¼±
  • battle line
    Àü¼±
  • bay line
    ´ëÇǼ±;Ãø¼±
  • belt line
    ¼øÈ¯¼±
  • bread line
    »§¹è±ÞÀ»¹Þ´Â»ç¶÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á